The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
Abstract
Molecular chaperones, ubiquitin ligases and proteasome impairment have been implicated in several neurodegenerative diseases, including Alzheimer's and Parkinson's disease, which are characterized by accumulation of abnormal protein aggregates (e.g. tau and alpha-synuclein respectively). Here we report that CHIP, an ubiquitin ligase that interacts directly with Hsp70/90, induces ubiquitination of the microtubule associated protein, tau. CHIP also increases tau aggregation. Consistent with this observation, diverse of tau lesions in human postmortem tissue were found to be immunopositive for CHIP. Conversely, induction of Hsp70 through treatment with either geldanamycin or heat shock factor 1 leads to a decrease in tau steady-state levels and a selective reduction in detergent insoluble tau. Furthermore, 30-month-old mice overexpressing inducible Hsp70 show a significant reduction in tau levels. Together these data demonstrate that the Hsp70/CHIP chaperone system plays an important role in the regulation of tau turnover and the selective elimination of abnormal tau species. Hsp70/CHIP may therefore play an important role in the pathogenesis of tauopathies and also represents a potential therapeutic target.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Induction of Hsp70 by geldanamycin promotes tau degradation both in vitro and in vivo, whereas deletion of CHIP increases the accumulation of phosphorylated tau and caspase-3 cleaved tau [167, 171].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [167]
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371
Zou, J., Guo, Y., Guettouche, T., Smith, D. F., & Voellmy, R. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81588-3 · Cited by 1,232
Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease
Auluck, P. K., Chan, H. Y. E., Trojanowski, J. Q., Lee, V. M.-Y., & Bonini, N. M. (2002) · Science · doi:10.1126/science.1067389 · Cited by 1,227
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 719
Tau protein aggregation: A therapeutic target for neurodegenerative diseases
Duggal, A., Mahindru, D., Baghel, K., Mehrotra, S., & Prajapati, V. K. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.11.012 · Cited by 2
Nishanth, D. S., Sinha, U., Verma, T., Kalidass, B., Thirumuruganandham, S. P., & Muthukaliannan, G. K. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01659-6 · Cited by 2
Molecular and environmental drivers of tau post-translational modifications and tau pathology
Price, T. M., Tucker, A. E., & Funk, K. E. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103223 · Cited by 2
Protein clearance mechanisms and their demise in age-related neurodegenerative diseases
Sáez, I., & Vı́lchez, D. (2015) · AIMS molecular science · doi:10.3934/molsci.2015.1.1 · Cited by 2
Heat Shock Proteins, Unfolded Protein Response Chaperones and Alzheimer’s Disease
Magrané, J., & Querfurth, H. W. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8231-3_2 · Cited by 2
Chaperone Suppression of Aggregated Protein Toxicity
Wacker, J. L., & Muchowski, P. J. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_8 · Cited by 2
The Amyloid _-Protein and Alzheimer's Disease
Teplow, D. B., Yang, M., Roychaudhuri, R., Pang, E. S., Huynh, T. V., Chen, M., & Beroukhim, S. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-2 · Cited by 2
Astrocytes as Targets for Neurological Gene Therapy
Imura, T., & Sofroniew, M. V. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-8 · Cited by 2
Targeting Proteasomal Degradation of Soluble, Misfolded Proteins
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801944-3.00003-5 · Cited by 2
Taillandier, D. (2021) · Biologie Aujourd hui · doi:10.1051/jbio/2021006 · Cited by 2
Frontotemporal lobar degeneration
Kim, B., Viera-Ortiz, A., Phan, J. M., Irwin, D. J., & Lee, E. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00041-1 · Cited by 3
Tu, Z., Tang, L., Abo‐Raya, M. H., Sun, M., Shen, H., & Wang, Y. (2023) · Gene · doi:10.1016/j.gene.2023.147945 · Cited by 2
Ubiquitin Mediated Posttranslational Modification of Proteins Involved in Various Signaling Diseases
LAVANYA, V. A., Jamal, S., & Ahmed, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00005-9 · Cited by 2
Plant E3 Ligases as Versatile Tools for Novel Drug Development and Plant Bioengineering
Al‐Saharin, R., Mooney, S., & Hellmann, H. A. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160691-00212 · Cited by 2
Fibrilpaint20 directs the ubiquitin–proteasome system to Tau amyloid fibrilsPreprint
Dekker, F. A., Pedrola, J. A., van Weert, E., den Breejen, A., Peters, L., Poza-Rodriguez, A., Mayer, G., Singh, S., Vertegaal, A. C. O., Friedler, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.27.609886 · Cited by 2
Chaperone-directed ubiquitylation maintains proteostasis at the expense of longevity
Pokrzywa, W., Lorenz, R., & Hoppe, T. (2017) · Worm · doi:10.1080/21624054.2017.1371403 · Cited by 2
Quantification of Methylation and Phosphorylation Stoichiometry
Ayoub, C. A., Moore, K. I., & Kuret, J. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3629-9_13 · Cited by 1
Mechanism Underlying Major Neurodegenerative Disorders
Chongtham, A., & Agrawal, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_2 · Cited by 1
Duckhorn, J. C., Kim, D. K., & Huang, Y. A. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00243 · Cited by 2
The Roles of Moonlighting Nicotinamide Mononucleotide Adenylyl Transferases in Cell Physiology
Lee, Y., & Lin, S.-J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189098 · Cited by 2
Prefoldin 5 is a microtubule-associated protein that suppresses Tau aggregation and neurotoxicity
Bisht, A., Pippadpally, S., Majumder, S., Gopi, A. T., Das, A., Sahi, C., Ramaswami, M., & Kumar, V. (2024) · eLife · doi:10.7554/elife.104691.3 · Cited by 4
Dysfunctional Ubiquitin-Proteasome System and Consequences: Disease Mechanism
Milmile, M., Singh, S., Pandey, A., Ahire, N., & Chawla, R. (2026) · Springer eBooks · doi:10.1007/978-981-95-6099-8_2 · Cited by 1
Ubiquitin signatures on aggregating proteins in neurodegeneration
Sahoo, S., Padhy, A. A., Shivani, K., Misra, A., & Mishra, P. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253046 · Cited by 1
Tang, Z., Xie, H., Xu, Y., Zhou, Z., Lu, F., Wu, Q., Liang, W., Zhong, M., & Li, S. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s602287 · Cited by 1
Oosterlynck, M., Fichter, L., Leroux, É., Eddarkaoui, S., Bouillet, T., Lefebvre, C., Nguyen, M., Maurage, C., Accart, B., Dupré, E., et al. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01250-1 · Cited by 1
Molecular Chaperones as Potential Therapeutic Targets for Neurological Disorders
Delenclos, M., & McLean, P. J. (2013) · Royal Society of Chemistry eBooks · doi:10.1039/9781849739689-00392 · Cited by 1
The Role of Hsp70 and Its Co-Chaperones in Protein Misfolding, Aggregation and Disease
van der Spuy, J., Cheetham, M. E., & Chapple, J. P. (2007) · Springer eBooks · doi:10.1007/978-0-387-49310-7_11 · Cited by 1
Cells and Fugu Response to Capsid of BFNNV Genotype
Mao, M., Jiang, J., Xu, J. W., et al. (2023) · Viruses · doi:10.3390/v15040988 · Cited by 1
Site‐Specific Ubiquitination of Tau Amyloids Promoted by the E3 Ligase CHIP
Parolini, F., Kachoie, E. A., Leo, G., Civiero, L., Bubacco, L., Arrigoni, G., Munari, F., Assfalg, M., D’Onofrio, M., & Capaldi, S. (2023) · Angewandte Chemie · doi:10.1002/ange.202310230 · Cited by 1
Neurodegeneration models in Drosophila
Roy, B., & Jackson, G. R. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920585.012 · Cited by 1
HSF Inhibits the Progression of Age-Related Neurodegenerative Diseases
Kondo, N., Katsuno, M., Riku, Y., & Sobue, G. (2016) · Springer eBooks · doi:10.1007/978-4-431-55852-1_11 · Cited by 1
Nano-Chaperones: Nanoparticles Acting as Artificial Chaperones
Boridy, S., & Maysinger, D. (2013) · Regenerative medicine, artificial cells and nanomedicine · doi:10.1142/9789814472869_0019 · Cited by 1
Current and Future Therapies for Alzheimer Disease
Chakrabarty, P., Das, P., & Golde, T. E. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch34 · Cited by 1
Nagai, Y. (2017) · Journal of Rare Diseases Research & Treatment · doi:10.29245/2572-9411/2017/3.1106 · Cited by 1
Liu‐Yesucevitz, L., Bilgutay, A. N., Zhang, Y., et al. (2011) · PLoS ONE · doi:10.1371/annotation/7d880410-06e3-4fe3-a8f1-e84c89bcf8d0 · Cited by 1
Self-citationXu, L., Li, M., Wei, A., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1758813/v1 · Cited by 1
Nadel, C. M., Wucherer, K., Oehler, A., Thwin, A. C., Basu, K., Callahan, M. D., Southworth, D. R., Mordes, D. A., Craik, C. S., & Gestwicki, J. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553575 · Cited by 1
Unnikrishnan, A., Chung, D. H., Connelly, E. J., Chuo, S., Devi, S., Thwin, A. C., Nadel, C. M., Tse, E., Gestwicki, J. E., Craik, C. S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.15.654159 · Cited by 1
Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease
Chimal-Juárez, E., Patel, H., Jury-Garfe, N., Dabin, L. C., Vidal, R., Kim, J., & Lasagna-Reeves, C. A. (2026) · bioRxiv · doi:10.64898/2026.05.12.724684
Mutant ubiquitin and the proteasome in Alzheimer's disease
de Vrij, F. M. S. (2005) · UvA-DARE (University of Amsterdam)
Therapeutics: Harnessing the Power of Molecular and Pharmacological Chaperones
Gross, D. S., Klein, R. L., & Witt, S. N. (2011) · Wiley eBooks · doi:10.1002/9781118063903.ch12
Characterization of the Ubc13-Mms2 Lysine-63-linked ubiquitin conjugating complex
Pastushok, L. (2006) · University Library - University of Saskatchewan (University of Saskatchewan)
Using Drosophila to Reveal Insight into Protein Misfolding Diseases
Bilen, J., & Bonini, N. M. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch10
Regional lysosomal malfunction underlies the selectivity of alpha-synuclein neurodegeneration
Malkus, K. A. (2011) · Scholarly Commons (University of Pennsylvania)
Pin1: A New Enzyme Pivotal for Protecting Against Alzheimer’s Disease
Nakamura, K., Ma, S. L., & Lu, K. P. (2011) · InTech eBooks · doi:10.5772/20852
Targeting the Protein Quality Control (PQC) Machinery
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801944-3.00002-3
The cytosolic fate of ricin A chain in target cells
Hart, P. J. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33594793
Duff, K., Krishnamurthy, P., Planel, E., & Hutton, M. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_13
Targeting Protein Quality Control Pathways in Spinal and Bulbar Muscular Atrophy
Wang, A. M. (2012) · Deep Blue (University of Michigan)
Age-associated increases in FKBP51 facilitate tau neurotoxicity
Blair, L. J. (2014) · Digital Commons - University of South Florida (University of South Florida)
A role for the ubiquitin domain protein HERP in ER-associated protein degradation
Schulze, A. (2007) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15575
Non‐amyloid Approaches To Alzheimer's Disease
Veng, L., Savage, M. J., Barrow, J. C., & Zerbinatti, C. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc253
Structural Basis for Ternary Complex Formation between Tau, Hsp90, and FKBP51
Barrett, A. S., Wu, H., Kashtanov, S., & Daughdrill, G. W. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.11.2162
Past, Present, and Future: The Behavioral Sciences.
Darley, J. G. (1971) · Contemporary Psychology · doi:10.1037/014015
Molecular Mechanisms of Tau Protein Aggregation Inhibition
Akoury, E. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4145
Sistemas neuromodulatórios: implicações fisiopatológicas
Carrettiero, D. C. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2008.tde-16062008-174159
The Chaperone-assisted E3 Ligase C Terminus of Hsc70-interacting Protein (CHIP) Targets PTEN for
Ahmed, S. F., Deb, S., Paul, I., Chatterjee, A., Mandal, T., Chatterjee, U., & Ghosh, M. K. (2012)
Role of C-terminus of HSC70 interacting protein in determining neuronal fate in acute injury
Stankowski, J. N. (2011)
Frasier, M. A., Frausto, S. F., Lewicki, D., Golbe, L. I., & Wolozin, B. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_11
Anderson-Mooney, A. J., & Abisambra, J. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00012-4
Szargel, R., Rott, R., & Engelender, S. (2008)
Proteasomal Degradation of Soluble, Misfolded Proteins
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800186-8.00003-1
Targeting the Protein Quality Control (PQC) Machinery
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800186-8.00002-x
Dickey, C., & Clark, K. P. (2006)
Protein Aggregation and Neurodegeneration: Tauopathies and Synucleinopathies
Goedert, M. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch2
Rakshit, M. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72725
Role of Molecular Chaperone Network in Understanding In Vitro Proteotoxicity
Srivastava, T., Sharma, S., & Priya, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804667-8.00008-0 · Cited by 1
Sinadinos, C., & Mudher, A. K. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7061-9_5
Lu, W., Kim, J., Tabara, S., Kwon, C., Mizukami, H., Kimura, K., & Fukamizu, A. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.077
The cochaperone and ubiquitin ligase CHIP in protein quality control
Dai, Q. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/3tfn-ca45
Thiol-Based Redox Signaling: Impacts on Molecular Chaperones and Cellular Proteostasis
Ford, A. E., & Morano, K. A. (2019) · Heat shock proteins · doi:10.1007/978-3-030-03952-3_1
Wong, E. S. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00078-6
THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
Cloyd, R. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.271
On some topological concepts via the lattice of closed sets
Mukherjee, M., & Sengupta, A. (2004) · Revista de la Academia Canaria de Ciencias: = Folia Canariensis Academiae Scientiarum
Gallo, J., Noble, W. J., & Martin, T. R. (2007)
Exploring the human Hsp70-Hop-Hsp90 system for Tau recognition
Moll, A. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9131
Rodent models of Alzheimer’s disease
Kasza, Á. (2018) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.9743
Heat Shock Proteins for Neurological Gene Therapy
Howarth, J. L., Kelly, S., & Uney, J. B. (2006) · CRC Press eBooks · doi:10.3109/9781420016390-5
CHIP ubiquitin ligase is involved in the nucleolar stress managementPreprint
Piechota, M. J., Biriczová, L., Kowalski, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.17.492288
Li, G., Xiao, K., Li, Y., Gao, J., He, S., & Li, T. (2022) · Research Square · doi:10.21203/rs.3.rs-2182862/v1
Villavicencio-Tejo, F., & Quintanilla, R. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00003-2
The Mechanistic Approach Involved in the Progression of Neurodegenerative Disorders
Rather, M. A., Khan, A., Alsharani, S., Jahan, S., Siddiqui, A. J., Mehan, S., & Alexiou, A. T. (2023) · Springer eBooks · doi:10.1007/978-981-99-3848-3_2
Bianchi, C., Alvarez‐Castelao, B., Sebastián‐Serrano, Á., Lauro, C. D., Soria-Tobar, L., Nicke, A., Engel, T., & Dı́az-Hernández, M. (2023) · Figshare · doi:10.6084/m9.figshare.23354460
Li, R., Du, Y., Zhou, Y., et al. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01232-4
Prefoldin 5 is a microtubule-associated protein that suppresses Tau-aggregation and neurotoxicityPreprint
Bisht, A., Pippadpally, S., Majumder, S., Gopi, A. T., Das, A., Sahi, C., Ramaswami, M., & Kumar, V. (2024) · eLife · doi:10.7554/elife.104691.1
Molecular and Cellular Mechanisms of Primary Tauopathies
Gong, S., & Gan, L. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0056
Cocktail gene therapy (CGT) for neurodegenerative diseases: Targeting protein clearance systems
Zhang, H., & Teplow, D. B. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111814
Prefoldin 5 is a microtubule-associated protein that suppresses Tau-aggregation and neurotoxicityPreprint
Bisht, A., Pippadpally, S., Majumder, S., Gopi, A. T., Das, A., Sahi, C., Ramaswami, M., & Kumar, V. (2025) · eLife · doi:10.7554/elife.104691.2
Molecular chaperones mediated proteostasis depletion: A cause of neurodegeneration?
Kinger, S., Choudhary, A., Kumar, P., Jagtap, Y. A., Sharma, V., Dhiman, R., Prasad, A., Verma, R., Chinnathambi, S., & Mishra, A. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.033
Therapeutic targets in diabetic peripheral neuropathy: heat shock proteins
Yin, C., Lv, J., Huang, S., Lang, C., Zhao, Y., Wang, G., Kan, J.-M., & Wang, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1729488
Höhfeld, J., Böhse, K., Genau, M., et al. (2007) · Springer eBooks · doi:10.1007/978-0-387-49310-7_10
Bianchi, C., Alvarez‐Castelao, B., Sebastián‐Serrano, Á., Lauro, C. D., Soria-Tobar, L., Nicke, A., Engel, T., & Dı́az-Hernández, M. (2023) · Figshare · doi:10.6084/m9.figshare.23354463
Xu, L., Li, M., Wei, A., Yang, M., Li, C., Liu, R., Zheng, Y., Chen, Y., Wang, Z., Wang, K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21275870
Synergistic MAPT mutations as a platform to uncover modifiers of tau pathogenesisPreprint
Bryan, M. R., Almeida, M. F., Pellegrino, K., Opland, C. K., Paulakonis, J. E., McGillion-Moore, J., Trzeciakiewicz, H., King, D. P., Tian, X., Tseng, J., et al. (2025) · eLife · doi:10.7554/elife.109145 · Cited by 1
Synergistic MAPT mutations as a platform to uncover modifiers of tau pathogenesisPreprint
Bryan, M. R., Almeida, M. F., Pellegrino, K., Opland, C. K., Paulakonis, J. E., McGillion-Moore, J., Trzeciakiewicz, H., King, D. P., Tian, X., Tseng, J., et al. (2025) · eLife · doi:10.7554/elife.109145.1
Metadata
- Authors
- Petrucelli, L.
- Affiliations
- Mayo Clinic in Florida (US)
- Corresponding author
- Petrucelli, L.
- ORCID
- Petrucelli, L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01-28
- Volume
- 13
- Issue
- 7
- Pages
- 703-714
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2168079270
- Cited by
- 723
- References
- 41
- Citations by year
- 2026: 29 · 2025: 36 · 2024: 32 · 2023: 32 · 2022: 37 · 2021: 37 · 2020: 36 · 2019: 25 · 2018: 35 · 2017: 31 · 2016: 31 · 2015: 38 · 2014: 34 · 2013: 28 · 2012: 31
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS041816, R01-NS41816-01)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- CHIP, HSP70, tau protein, ubiquitination, protein degradation, tau aggregation, molecular chaperones, ubiquitin ligase, geldanamycin, heat shock factor 1, tauopathy, Alzheimer's disease, Parkinson's disease, proteasome
- MeSH terms
- Heat Shock Transcription Factors, Animals, Cell Line, Detergents, DNA-Binding Proteins, Genetic Vectors, Humans, Immunohistochemistry, Lac Operon, Models, Genetic, Mutation, Nuclear Proteins, Protein Binding, Quinones, Subcellular Fractions, Transcription Factors, Transfection, Blotting, Western, Benzoquinones, tau Proteins, Molecular Chaperones, HSP70 Heat-Shock Proteins, Transgenes, COS Cells, Ubiquitin, Drosophila Proteins, Ubiquitin-Protein Ligases, Cell Line, Tumor, Lactams, Macrocyclic, Immunoprecipitation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review